Andexanet alfa for oral fxa inhibitor-associated major acute intracerebral hemorrhage: insights into clinically relevant thromboembolic events from the ANNEXA-I study - Mateo Porres-Aguilar; Luis Antonio Meillon-Garcia; João Carlos de Campos Guerra (Jornal Vascular Brasileiro)